For some manufacturers, the goal was to be fully compliant with the DSCSA, including both serialization and aggregation, from day one. Enacted by Congress on Nov. 27, 2013, the US Drug Supply Chain ...
Pharmaceutical counterfeiting is on the rise – and a growing health and safety issue with deep consequences for consumers and manufacturers alike. A number of factors contribute to counterfeiting, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results